United Therapeutics
UTHR
UTHR
360 hedge funds and large institutions have $4.6B invested in United Therapeutics in 2018 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 108 increasing their positions, 139 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
22% less repeat investments, than reductions
Existing positions increased: 108 | Existing positions reduced: 139
32% less call options, than puts
Call options by funds: $6.29M | Put options by funds: $9.31M
Holders
360
Holding in Top 10
5
Calls
$6.29M
Puts
$9.31M
Top Buyers
| 1 | +$27.5M | |
| 2 | +$26M | |
| 3 | +$20.4M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$15.6M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$14.6M |
Top Sellers
| 1 | -$40.9M | |
| 2 | -$37.3M | |
| 3 | -$21.6M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$15.5M |
| 5 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$14.7M |